• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS RUBELLA IGG IMMUNOASSAY; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS RUBELLA IGG IMMUNOASSAY; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA Back to Search Results
Model Number RUBELLA IGG
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/19/2021
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).The customer provided the samples for investigation.For patient 1, the investigation's results are below: rubella igg results: 60.7 iu/ml reactive and 55.2 iu/ml reactive, rubella igm: non-reactive for both samples.For patient 2, the investigation's results are below: rubella igg result: 15.2 iu/ml reactive, rub igm: non-reactive.The investigation confirmed the customer's results.The investigation is ongoing.Unique device identifier (udi): (b)(4).
 
Event Description
The initial reporter received questionable elecsys rubella igg immunoassay results for two patients tested on a cobas 8000 e 801 module serial number (b)(4).The initial rubella igg results were reported outside the laboratory.The customer performed repeat testing with the cobas 8000 e 801 module and an abbott analyzer for confirmation.On (b)(6) 2021 and at 13:35, patient 1's elecsys rubella igg result was 60.1 iu/ml reactive.At 14:27, patient 1's repeat elecsys rubella igg result was 61.0 iu/ml reactive.At 17:43, patient 1's rubella igg result was 5.0 iu/ml grayzone with an abbott architect.On (b)(6) 2021 and at 14:22, patient 2's elecsys rubella igg result was 15.5 iu/ml reactive.Patient 2's rubella igg result at a different laboratory with an unknown laboratory methodology was 15.5 iu/ml grayzone.
 
Manufacturer Narrative
The customer's calibration and qc data were acceptable.The customer's sample pre-analytical data was ok.The samples were further investigated with the platelia rubella igg assay, the mikrogen recomblot rubella igg, and by neutralization.Mikrogen recom blot rubella igg results: patient 1: reactive patient 2: reactive the mikrogen recomblot rubella igg was determined positive.Platelia rubella igg resuts: patient 1: reactive patient 2: reactive the platelia rubella igg assay was determined positive.Neutralization results: patient 1: successful neutralization patient 2: neutralization was not successful for patient 1, the successful neutralization result confirmed the presence of anti-rubella igg antibodies.For patient 2, the neutralization was not successful due to the low signal level before neutralization.Based on the positivity in the platelia rubella igg assay and the reactivities obtained in the mikrogen recomblot rubella igg, the samples are regarded as positive for rubella igg.Due to the supportive data obtained with the platelia rubella igg, the mikrogen recomblot rubella igg, and the neutralization experiment these three samples are regarded correctly positive in the elecsys rubella igg.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS RUBELLA IGG IMMUNOASSAY
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11365148
MDR Text Key233891385
Report Number1823260-2021-00537
Device Sequence Number1
Product Code LFX
Combination Product (y/n)N
PMA/PMN Number
K072617
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 04/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2021
Device Model NumberRUBELLA IGG
Device Catalogue Number07027770190
Device Lot Number48859001
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 01/27/2021
Initial Date FDA Received02/23/2021
Supplement Dates Manufacturer Received01/27/2021
Supplement Dates FDA Received04/05/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-